Delivery Order SPE2DB24D2011-SPE2DB25FBPDC
- Not listed
- This federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,768.80 firm fixed-price delivery order contract has a period of performance through March 2, 2022. The contract was awarded on an unrestricted basis, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an Indefinite...
- This federal contract award is for the pharmaceutical product Repatha 140 mg/mL SureClick, which was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,017 firm fixed-price delivery order has a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Repatha 140 mg/mL SureClick medication. The $61,783.85 firm fixed-price delivery order has an ultimate completion date of October 25, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Repatha 140 mg/ml SureClick medication. The contract, valued at $1,355.76, is a Delivery Order awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 28, 2024. The contract type is Firm Fixed Price, and there is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Repatha 140 mg/ml SureClick. The $1,577.97 firm fixed-price delivery order is not designated with a set-aside and has an ultimate completion date of November 20, 2024. Amerisourcebergen is the prime contractor and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the pharmaceutical product Repatha 140 mg/mL SureClick, awarded to the Amerisourcebergen Drug Corp's Corporate Office Division. The $3,104.67 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation, a major supplier of pharmaceuticals and medical supplies to the U.S. government, particularly...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClick medication to the Defense Logistics Agency (DLA). The $4,081.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 10, 2022 with a completion date of January 11, 2022. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of the medication Repatha (140 mg/ml SureClick) to the Defense Logistics Agency (DLA). The Delivery Order is valued at $4,207.92 and has a firm fixed price. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated with any set-aside requirements, indicating open competition. The contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injection medication. The $1,016.82 firm fixed price delivery order has a completion date of September 14, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBPDCDelivery Order
This federal contract award is for the pharmaceutical product Repatha 140 mg/mL SureClick, awarded to the prime contractor Amerisourcebergen Drug Corp. The $37,299.26 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued at $750,000, to provide a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.3k | 11/5/24 |